The FDA does not have a four day rule. They do not have to report anything to the SEC that is material and do not have the same rules. They have their own rules regarding postings to the Federal Register. Amarin because it is required to follow SEC regulations was required to report receiving material information within the four days. JT was right to go ahead and report this to shareholders and the SEC, he did the right thing. The FDA is not subject to the same rules.
FDA has no time limit on when it must post an AC on the Federal Register except it should be filed 14 days prior to the AC. How did you miss every single post where this was pointed out about Agile Therapeutics? FDA informed them of an AC 1 1/2 months ago (AC is Oct. 30) but it's still not published in the FR.
News 
Market Data 
Discover 
